January 21, 2015
A federal judge has refused to dismiss a patent suit against Mylan Pharmaceuticals Inc. and held that the company consented to jurisdiction in Delaware, reaching the opposite conclusion from a different judge in the state about how a U.S. Supreme Court decision on jurisdiction applies to drug patent cases.